Chris Kedong Wang

Chris Kedong Wang serves as a Postdoctoral Research Fellow in the Department of Immunology and Microbiology at the University of Copenhagen's Skin Immunology Research Center. His research bridges immunological mechanisms with oncological applications, focusing on cancer cell signaling and therapeutic resistance.

Research interests span inflammatory signaling pathways, cancer glycobiology, and therapy resistance mechanisms in urological malignancies. His work examines how chondroitin sulfate modifications drive prostate cancer progression and how genomic alterations enable immune evasion in bladder cancer. Current investigations explore ZBP1-mediated inflammatory signaling independent of cell death pathways.

Wang's publication record demonstrates significant impact in high-impact journals including Nature Communications and EMBO Reports, with multiple studies exceeding 100 citations. His collaborative network spans international institutions with emphasis on translational cancer research.

As member of the Skin Immunology Research Center, Wang contributes to multidisciplinary projects investigating the intersection of immunological processes and cancer biology. His laboratory work employs advanced cellular and molecular techniques to dissect signaling pathways relevant to therapeutic development.